Aclaris Therapeutics, Inc. (ACRS)
$3.38-2.59%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $472M
- Beta
- 0.80
- P/E (TTM)
- -5.83
- Short % float
- 17.40%
- Days to cover
- 6.5
- SI change
- +13.2%
- 1W
- -0.59%
- 1M
- -38.88%
- vs SPY 1W
- -0.45%
- vs SPY 1M
- -41.38%
Industry peers
FMP comparable companies · ranked by market cap
- ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$45.95-0.98%
- TRAXSELLFirst Tracks Biotherapeutics Inc$1.1BQ 80$31.85-6.96%
- ODTXSELLOdyssey Therapeutics, Inc.$913MQ 19$19.00-5.59%
- MLTXSELLMoonLake Immunotherapeutics$910MCRISISQ -1$10.82-2.53%
- ALMSSELLAlumis Inc.$884MCRISISQ 0$7.16-7.08%
- ATTOSELLAttovia Therapeutics, Inc.$698MQ -46$16.21+0.89%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 11
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-37.0%
REV YoY-
ROE-61.6%
EPS YoY-
ROA-42.1%
GROSS96
OP-1050
NET-921
[VALUATION]
P/E TTM-5.83
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B3.87
P/FCF-
EV/EBITDA-6.01
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO3.46
ND/EBITDA-
BETA0.80
Company news
FAQ
- What is LOPJLB’s current signal on ACRS?
- LOPJLB’s latest quantitative signal on Aclaris Therapeutics, Inc. (ACRS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ACRS in?
- Aclaris Therapeutics, Inc. (ACRS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Aclaris Therapeutics, Inc. (ACRS) do?
- Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial un…